Back to Dividend Stocks
Supernus Pharmaceuticals Inc. (SUPN) logo

Supernus Pharmaceuticals Inc.

S&P 500

SUPN/Healthcare · Drug Manufacturers - Specialty & Generic/NASDAQ

Stock Price

$44.75

Stock Price$44.75P/E40.7MCap2.6BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

SUPN does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. Its primary function is to innovate therapeutic solutions that address unmet medical needs in neurology and psychiatry. Known for its robust research and development efforts, Supernus has a portfolio that includes treatments for epilepsy, migraine, attention deficit hyperactivity disorder (ADHD), and bipolar disorder. The company's significant contributions to the CNS field have made it a notable entity in the pharmaceutical industry. Supernus operates through a combination of proprietary products and strategic partnerships, ensuring a steady pipeline of new medications. This focus on CNS disorders highlights its specialization within healthcare, impacting patient lives by improving management and treatment of these conditions. Supernus Pharmaceuticals' market significance is underscored by its dedication to enhancing the quality of life for patients through advanced, targeted therapies. By leveraging extensive research, clinical trials, and regulatory expertise, Supernus continues to play an important role in the pharmaceutical sector's innovation landscape.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

FCF Payout Ratio

0.00%

52-Week Range

$30.83 - $59.68

Earnings & Profitability

SUPN earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

SUPN Dividend Calculator

Total Investment

$4,475.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is SUPN's current dividend yield?
Supernus Pharmaceuticals Inc. (SUPN) currently has a dividend yield of 0.00%, based on a stock price of $44.75 and an annual dividend of $0.00.
When is SUPN's next dividend payment date?
SUPN's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does SUPN pay in dividends per year?
Supernus Pharmaceuticals Inc. pays dividends unknown. Annual dividend data is not yet available.
Has SUPN been increasing its dividend?
Supernus Pharmaceuticals Inc. has grown its dividend at a 5-year CAGR of —.
Is SUPN's dividend safe?
Supernus Pharmaceuticals Inc. has a payout ratio of —. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is SUPN's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Supernus Pharmaceuticals Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track SUPN Dividends with OnlyDividends

What will SUPN actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.